(Q32134744)

English

5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 July 2017

5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release (English)

1 reference

Europe PubMed Central

6 July 2017

0 references

author name string

J Ichikawa

1

1 reference

Europe PubMed Central

6 July 2017

H Ishii

2

1 reference

Europe PubMed Central

6 July 2017

S Bonaccorso

3

1 reference

Europe PubMed Central

6 July 2017

W L Fowler

4

1 reference

Europe PubMed Central

6 July 2017

I A O'Laughlin

5

1 reference

Europe PubMed Central

6 July 2017

H Y Meltzer

6

1 reference

Europe PubMed Central

6 July 2017

language of work or name

0 references

publication date

1 March 2001

1 reference

Europe PubMed Central

6 July 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

Journal of Neurochemistry

1 reference

Europe PubMed Central

6 July 2017

76

1 reference

Europe PubMed Central

6 July 2017

5

1 reference

Europe PubMed Central

6 July 2017

1521-1531

1 reference

Europe PubMed Central

6 July 2017

5-Hydroxytryptamine2 and 5-hydroxytryptamine1A receptors mediate opposing responses on membrane excitability in rat association cortex

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00154.X

21 January 2018

The 5-HT1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00154.X

21 January 2018

Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00154.X

21 January 2018

Electrophysiological evidence for a functional interaction between 5-HT1A and 5-HT2A receptors in the rat medial prefrontal cortex: an iontophoretic study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00154.X

21 January 2018

Behavioural evidence for a functional interaction between central 5-HT2 and 5-HT1A receptors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00154.X

21 January 2018

Radioreceptor binding profile of the atypical antipsychotic olanzapine.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00154.X

21 January 2018

Actions of clozapine and haloperidol on the extracellular levels of excitatory amino acids in the prefrontal cortex and striatum of conscious rats.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00154.X

21 January 2018

Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin receptors: evidence for a lack of selectivity

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00154.X

21 January 2018

Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00154.X

21 January 2018

Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of release.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00154.X

21 January 2018

Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00154.X

21 January 2018

Risperidone inhibits 5-hydroxytryptaminergic neuronal activity in the dorsal raphe nucleus by local release of 5-hydroxytryptamine

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00154.X

21 January 2018

Enhanced cortical dopamine output and antipsychotic-like effects of raclopride by alpha2 adrenoceptor blockade.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00154.X

21 January 2018

Relationship between dopaminergic and serotonergic neuronal activity in the frontal cortex and the action of typical and atypical antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00154.X

21 January 2018

Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00154.X

21 January 2018

R(+)-8-OH-DPAT, a 5-HT1A receptor agonist, inhibits amphetamine-induced serotonin and dopamine release in rat medial prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00154.X

21 January 2018

Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00154.X

21 January 2018

Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00154.X

21 January 2018

Regulation of glutamate release via NMDA and 5-HT1A receptors in guinea pig dentate gyrus

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00154.X

21 January 2018

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00154.X

21 January 2018

Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00154.X

21 January 2018

Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00154.X

21 January 2018

Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00154.X

21 January 2018

Clozapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00154.X

21 January 2018

5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00154.X

21 January 2018

Postsynaptic 5-hydroxytryptamine(1A) receptor activation increases in vivo dopamine release in rat prefrontal cortex

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00154.X

21 January 2018

The regulation of dopamine release from nigrostriatal neurons in conscious rats: the role of somatodendritic autoreceptors.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00154.X

21 January 2018

Characterization and Pharmacological Responsiveness of Dopamine Release Recorded by Microdialysis in the Substantia Nigra of Conscious Rats

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00154.X

21 January 2018

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00154.X

21 January 2018

Effect of adjunctive treatment with serotonin-1A agonist tandospirone on memory functions in schizophrenia.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00154.X

21 January 2018

Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00154.X

21 January 2018

Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00154.X

21 January 2018

Enhancement of antipsychotic-like properties of the dopamine D2 receptor antagonist, raclopride, by the additional treatment with the 5-HT2 receptor blocking agent, ritanserin, in the rat.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00154.X

21 January 2018

Enhancement of antipsychoticlike properties of raclopride in rats using the selective serotonin2A receptor antagonist MDL 100,907.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00154.X

21 January 2018

The in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D1, D2, D3, 5HT2A and muscarinic receptors.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00154.X

21 January 2018

Identifiers

10.1046/J.1471-4159.2001.00154.X

1 reference

Europe PubMed Central

6 July 2017

1 reference

Europe PubMed Central

6 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q32134744&oldid=1774675115"